Loading...
In Vitro Susceptibility of Hepatitis C Virus Genotype 1 through 6 Clinical Isolates to the Pangenotypic NS3/4A Inhibitor Voxilaprevir
Voxilaprevir is a direct-acting antiviral agent (DAA) that targets the NS3/4A protease of hepatitis C virus (HCV). High sequence diversity of HCV and inadequate drug exposure during unsuccessful treatment may lead to the accumulation of variants with reduced susceptibility to DAAs, including NS3/4A...
Na minha lista:
| Udgivet i: | J Clin Microbiol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6440772/ https://ncbi.nlm.nih.gov/pubmed/30728196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01844-18 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|